San Diego-primarily based Viking Therapeutics marked alone as a serious competitor during the weight loss drug industry in February just after revealing promising details from a mid-phase demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when specified like a weekly injection and in March the compa… Read More